<DOC>
	<DOCNO>NCT02219932</DOCNO>
	<brief_summary>The primary objective determine whether prolonged-release fampridine ( 10 mg twice daily ) clinically meaningful effect participant-reported walking ability 24-week study period . The secondary objective : determine whether prolonged-release fampridine 10 mg take twice daily ( BID ) clinically meaningful effect dynamic static balance , physical impact multiple sclerosis ( MS ) , upper extremity function 24-week study period ; evaluate criterion early assessment response fampridine predict clinically meaningful benefit walk ability balance ; assess safety tolerability prolonged-release fampridine 10 mg twice daily 24-week treatment period .</brief_summary>
	<brief_title>Efficacy Safety Study Prolonged-Release Fampridine Participants With Multiple Sclerosis</brief_title>
	<detailed_description />
	<mesh_term>Sclerosis</mesh_term>
	<mesh_term>Multiple Sclerosis</mesh_term>
	<mesh_term>4-Aminopyridine</mesh_term>
	<criteria>Key Must diagnosis primaryprogressive , secondaryprogressive , progressiverelapsing , relapsingremitting MS per revise McDonald Committee criterion [ McDonald 2001 ; Polman 2005 ] define Lublin Reingold [ Lublin Reingold 1996 ] least 3 month duration Must Expanded Disability Status Scale ( EDSS ) score 4 7 , inclusive Must walk impairment , deem Investigator Key History human immunodeficiency virus ( HIV ) Presence acute chronic hepatitis . Subjects evidence prior hepatitis infection serologically confirm resolve exclude study participation Known allergy fampridine , pyridinecontaining substance , inactive ingredient prolongedrelease fampridine tablet Creatinine clearance ( CrCl ) &lt; 80 mL/min History malignant disease Presence pulmonary disease A body mass index ( BMI ) â‰¥40 ( BMI formula : BMI = mass [ kg ] / [ height ( ) ] 2 ) NOTE : Other protocol define Inclusion/Exclusion criterion may apply .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>70 Years</maximum_age>
	<verification_date>January 2017</verification_date>
	<keyword>Fampridine</keyword>
</DOC>